Synthesis and antiviral activity of methyl derivatives of 9-[2-(phosphonomethoxy)ethyl]guanine

J Med Chem. 1992 Aug 7;35(16):2958-69. doi: 10.1021/jm00094a005.

Abstract

A number of methyl derivatives of 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG, 1) have been synthesized and tested in vitro for anti-herpes and anti-human immunodeficiency virus (HIV) activity. Among these analogues, (R)-2'-methyl-PMEG [(R)-3] and 2',2'-dimethyl-PMEG (7) demonstrated potent anti-HIV activity in the XTT assay with EC50 values of 1.0 and 2.6 microM, respectively. The corresponding (S)-2'-methyl-PMEG [(S)-3] was found to be less potent against HIV. In addition, the (R) and (S) enantiomers of 9-[3-hydroxy-2-(phosphonomethoxy)propyl]guanine (HPMPG, 8) were prepared for comparison of biological activity, and shown to be active and equipotent against herpesviruses, but inactive against HIV.

MeSH terms

  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / toxicity
  • Cell Line
  • Guanine / analogs & derivatives*
  • Guanine / chemical synthesis
  • Guanine / pharmacology
  • Guanine / toxicity
  • HIV / drug effects
  • Microbial Sensitivity Tests
  • Organophosphorus Compounds / chemical synthesis
  • Organophosphorus Compounds / pharmacology*
  • Organophosphorus Compounds / toxicity
  • Simplexvirus / drug effects
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Antiviral Agents
  • Organophosphorus Compounds
  • 9-((2-phosphonylmethoxy)ethyl)guanine
  • Guanine